Personalized genomic medicine (PGM)—medical care that is tailored to individuals based on their genetic makeup—has the potential to revolutionize the way providers diagnose and treat patients. By testing patients for clinically validated pharmacogenomic biomarkers, for instance, physicians will be able to tailor drug selection, dosage levels, and treatment duration in ways that avoid adverse drug reactions (Ramos et al., 2013). In many clinics, physicians are already utilizing this technology.
